1-5 of 5
R Becher
Close
Sort by
Journal Articles

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma

B Opalka, UB Wandl, R Becher, O Kloke, M Nagel-Hiemke, T Moritz, U Beer, S Seeber, N Niederle
Journal: Blood
Blood (1991) 78 (9): 2188–2193.
https://doi.org/10.1182/blood.V78.9.2188.2188
Published: 1991
Journal Articles

Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes

A Ganser, G Seipelt, A Lindemann, OG Ottmann, S Falk, M Eder, F Herrmann, R Becher, K Hoffken, T Buchner
Journal: Blood
Blood (1990) 76 (3): 455–462.
https://doi.org/10.1182/blood.V76.3.455.455
Published: 1990
Journal Articles

Isochromosome 17q in Ph1-negative leukemia: a clinical, cytogenetic, and molecular study [see comments]

R Becher, F Carbonell, CR Bartram
Journal: Blood
Blood (1990) 75 (8): 1679–1683.
https://doi.org/10.1182/blood.V75.8.1679.1679
Published: 1990
Journal Articles

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial

A Ganser, B Volkers, J Greher, OG Ottmann, F Walther, R Becher, L Bergmann, G Schulz, D Hoelzer
Journal: Blood
Blood (1989) 73 (1): 31–37.
https://doi.org/10.1182/blood.V73.1.31.31
Published: 1989
Journal Articles

Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia

U Duhrsen, M Uppenkamp, I Uppenkamp, R Becher, M Engelhard, E Konig, P Meusers, S Meuer, G Brittinger
Journal: Blood
Blood (1986) 68 (2): 577–585.
https://doi.org/10.1182/blood.V68.2.577.577
Published: 1986